# Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

> **NCT06707350** · NA · NOT_YET_RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 500 (estimated)

## Conditions studied

- Cardiopulmonary Bypass
- Cardiovascular Diseases
- Inflammatory Response During Cardiac Surgery

## Interventions

- **DEVICE:** Remote ischemic preconditioning (RIPC)
- **DEVICE:** sham condition (control group)

## Key facts

- **NCT ID:** NCT06707350
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707350, "Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06707350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*